AHSG and chronic kidney disease: Some studies have identified associations between low fetuin-A levels, accelerated progression of aortic VC and major adverse clinical events [103,104], whereas increased phosphorylated fetuin-A-containing CPPs have also been associated with increased aortic stiffness in patients with non-dialysis CKD [105].